AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Manchester’s health and life sciences sector is thriving, but as experts at Insider’s roundtable discussed, unlocking its full potential will require greater ...

Trump's tariffs could derail Europe's 2025 growth, say top Wall Street analysts. Goldman Sachs sees eurozone GDP at 0.7%, ...

In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

A planned investment deal between the Government and AstraZeneca is not going ahead because it did not “add up for the UK taxpayer”, science minister Sir Chris Bryant said.

A planned investment deal between the British government and AstraZeneca is not going ahead because it did not “add up for ...

If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities ...

The AstraZeneca PLC ADR AZN slipped 1.27% to $69.86 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.20% to ...

Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the ...